Drug Type Small molecule drug |
Synonyms Trichlormethiazide (JP17/USP/INN), Achletin, Fluitran + [9] |
Target |
Mechanism NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (09 Mar 1960), |
Regulation- |
Molecular FormulaC8H8Cl3N3O4S2 |
InChIKeyLMJSLTNSBFUCMU-UHFFFAOYSA-N |
CAS Registry133-67-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00658 | Trichlormethiazide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Heart Failure | JP | 22 Aug 1960 | |
Edema | US | 09 Mar 1960 | |
Hypertension | US | 09 Mar 1960 |
Not Applicable | 10 | Tolvaptan + Trichloromethiazide | jybmnhskxs(oondeikgid) = jxxfluxazw nvhyqvwkut (ybdetjsvah ) View more | Positive | 19 Oct 2020 | ||
jybmnhskxs(oondeikgid) = lgwhxxlplz nvhyqvwkut (ybdetjsvah ) View more |